Welcome to LookChem.com Sign In|Join Free

CAS

  • or

848475-20-7

Post Buying Request

848475-20-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

848475-20-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 848475-20-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,4,7 and 5 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 848475-20:
(8*8)+(7*4)+(6*8)+(5*4)+(4*7)+(3*5)+(2*2)+(1*0)=207
207 % 10 = 7
So 848475-20-7 is a valid CAS Registry Number.

848475-20-7Relevant articles and documents

Synthesis of zirconium phosphonate supported L-proline as an effective organocatalyst for direct asymmetric aldol addition

Angeloni, Marco,Piermatti, Oriana,Pizzo, Ferdinando,Vaccaro, Luigi

, p. 1716 - 1726 (2014/03/21)

Stable L-proline-functionalized zirconium methyl- and/or phenylphosphonates have been prepared as amorphous solids by the precipitation of (4R)-4-[(4′-phosphonobenzyl)oxy]-L-proline and methyl- and/or phenylphosphonic acid with ZrOCl2. The supported L-proline catalysts were tested in the direct asymmetric aldol addition between several ketones and p-substituted benzaldehydes. High yields, diastereoselectivities (anti/syn up to 92:8) and enantiomeric excesses (up to 99 % ee) have been achieved. Moreover, an easy protocol for the efficient recovery of the catalytic system by simple centrifugation has been defined, and the effective reuse of the catalyst has been reported in the representative aldol addition of cyclohexanone with p-nitrobenzaldehyde. This study has shown that these L-proline immobilized catalytic systems can be used at least six times without loss of activity and with reproducible anti/syn and ee values. Copyright

De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold

Potin, Dominique,Launay, Michele,Nicolai, Eric,Fabreguette, Maud,Malabre, Patrice,Caussade, Francois,Besse, Dominique,Skala, Stacey,Stetsko, Dawn K.,Todderud, Gordon,Beno, Brett R.,Cheney, Daniel L.,Chang, Chiehying J.,Sheriff, Steven,Hollenbaugh, Diane L.,Barrish, Joel C.,Iwanowicz, Edwin J.,Suchard, Suzanne J.,Dhar, T. G. Murali

, p. 1161 - 1164 (2007/10/03)

LFA-1 (leukocyte function-associated antigen-1), is a member of the β2-integrin family and is expressed on all leukocytes. The LFA-1/ICAM interaction promotes tight adhesion between activated leukocytes and the endothelium, as well as between T cells and antigen-presenting cells. Evidence from both animal models and clinical trials provides support for LFA-1 as a target in several different inflammatory diseases. This paper describes the de novo design, synthesis and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 848475-20-7